Immix Biopharma

0 followers


Immix Biopharma, Inc. (ImmixBio™) is a clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)™ in oncology and inflammation.

Industries

Headquarters

Stage

Employees

Links

Org chart

Ilya Rachman
Co-Founder & CEO

Ilya Rachman

Collapse
Gabriel Morris
CFO & Director
Graham Ross
Chief Medical Officer & Head of Clinical Development
Helen C. Hutchison Adams
Lead Independent Director, Audit Committee Chair
Sean Senn
Co-Founder